Pacira Biosciences Inc (NASDAQ:PCRX)
| 38.58 Delayed Data As of Mar 23 |  -0.73 / -1.86%Today’s Change | 35.35 Today|||52-Week Range 82.16 | -0.08% Year-to-Date |
Latest PCRX News | Press Releases
No recent news for Pacira Biosciences Inc.
Today’s Trading
| Previous close | 39.33 |
| Today’s open | 39.60 |
| Day’s range | 38.48 - 39.94 |
| Volume | 428,057 |
| Average volume (3 months) | 554,948 |
| Market cap | $1.9B |
Data as of 3:59pm ET, 03/23/2023
Growth & Valuation
| Earnings growth (last year) | -63.15% |
| Earnings growth (this year) | +30.06% |
| Earnings growth (next 5 years) | +26.70% |
| Revenue growth (last year) | +23.14% |
| P/E ratio | 113.5 |
| Price/Sales | 2.69 |
| Price/Book | 2.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GRFSGrifols SA | +0.28 | +4.21% |
| AMPHAmphastar Pharmaceut... | -0.02 | -0.05% |
| ---- | ||
| CPRXCatalyst Pharmaceuti... | -0.19 | -1.17% |
Data as of 4:00pm ET, 03/23/2023
Financials
| Next reporting date | May 4, 2023 |
| EPS forecast (this quarter) | $0.60 |
| Annual revenue (last year) | $666.8M |
| Annual profit (last year) | $15.9M |
| Net profit margin | 2.39% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Tampa, Florida |
Forecasts
